Siv Jönsson, Ph.D.

Senior Consultant

Portrait-of-Siv-Jonsson-Pharmetheus

Bio

  • Joined Pharmetheus in 2019, actively working in client projects, with continuous improvements and leading the learning agenda team
  • Expertise includes pharmacometrics, regulatory advice, and pediatric drug development, in hemophilia and across therapeutic areas
  • Previously worked as Researcher at Uppsala University, Sweden, where she had a part-time position to perform pharmacometric research, primarily by supervision of Ph.D. students, as Senior Lecturer and Researcher at Uppsala University, Sweden, Pharmacokinetic Assessor at the Medical Products Agency, Sweden, Senior Research Scientist and Pharmacometrician at AstraZeneca, Sweden, Pharmacokineticist at Kabi Pharma and Kabi Pharmacia, Sweden, and Pharmacist at the Swedish Poison Information Centre, Sweden
  • M.Sc. in Pharmacy (1988) and Ph.D. in Pharmacokinetics and Drug Therapy (2004) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativaPopulation pharmacokinetic and dose–response models of nepadutant, a selective antagonist of the NK₂ receptors, in infants with colicPopulation pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis [2]Population Pharmacokinetic Analysis of Etrolizumab in Patients with Moderately-to-Severely Active Ulcerative ColitisEnhancing Efficiency and Decision Quality in Parkinson’s Disease Drug Trials for LRRK2 Programs Using Item Response ModellingPopulation Exposure-Response Modeling of Oral Nepadutant Administration in Infants with Colic